1. Preliminary evidence of antitumour activity of Ipatasertib (Ipat) and Atezolizumab (ATZ) in glioblastoma patients (pts) with PTEN loss from the Phase 1 Ice-CAP trial (NCT03673787). (15th October 2021) Authors: Tiu, Crescens; Welsh, Liam; Jones, Timothy; Zachariou, Anna; Prout, Toby; Turner, Alison; Daly, Rob; Tunariu, Nina; Riisnaes, Ruth; Gurel, Bora; Crespo, Mateus; Carreira, Suzanne; Vivanco, Igor; Jenkins, Ben; Yap, Christina; Minchom, Anna; Banerji, Udai; deBono, Johann; Lopez, Juanita Journal: Neuro-oncology Issue: Volume 23: Supplement 4(2021) Page Start: iv10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗